Search
01/08/2022
Concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
Mena, M, Wang, X, Tous, S, Quiros, B, Clavero, O, Alejo, M, Morey, F, Taberna, M, Vintro, XL, Rubio, BL, Alos, L, Mehanna, H, Quint, W, Pawlita, M, Tommasino, M, Pavon, MA, Munoz, N, De Sanjose, S, Bosch, FX, Alemany, L. Concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study. Cancers. 2022; 14(15)DOI:10.3390/cancers14153787. PMID:35954451. IF:5.200(Q2/3D).
01/08/2022
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan
Guijarro, F, Bataller, A, Diaz-Beya, M, Garrido, A, Coll-Ferra, C, Vives, S, Salamero, O, Valcarcel, D, Tormo, M, Arnan, M, Sampol, A, Castano-Diez, S, Martinez, C, Suarez-Lledo, M, Fernandez-Aviles, F, Hernandez-Boluda, JC, Ribera, JM, Rovira, M, Brunet, S, Sierra, J, Esteve, J. Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan. BONE MARROW TRANSPLANTATION. 2022; 57(8)DOI:10.1038/s41409-022-01703-9. PMID:35643942. IF:4.800(Q1/2D).
01/08/2022
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype
Ramos-Campoy, S, Puiggros, A, Kamaso, J, Bea, S, Bougeon, S, Larrayoz, MJ, Costa, D, Parker, H, Rigolin, GM, Blanco, ML, Collado, R, Ancin, I, Salgado, R, Moro-Garcia, MA, Baumann, T, Gimeno, E, Moreno, C, Salido, M, Calvo, X, Calasanz, MJ, Cuneo, A, Nguyen-Khac, F, Oscier, D, Haferlach, C, Strefford, JC, Schoumans, J, Espinet, B. TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype. Cancers. 2022; 14(15)DOI:10.3390/cancers14153715. PMID:35954380. IF:5.200(Q2/3D).
01/08/2022
Medical education, specialty training, and emergency medicine: when the whole is more than the sum of its parts
Campmany, MP, Montiel-Dacosta, JA, Higa-Sansone, JL, Romeu, JR. Medical education, specialty training, and emergency medicine: when the whole is more than the sum of its parts. EMERGENCIAS. 2022; 34(4)DOI:. PMID:35833772. IF:5.500(Q1/2D).
01/08/2022
Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response
Dato, VA, Benitez-Amaro, A, Garcia, E, Claudi, L, Lhoest, MTL, Iborra, A, Guerra, JM, Escola-Gil, JC, Samouillan, V, Enrich, C, Chiabrando, G, Llorente-Cortes, V. Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 152DOI:10.1016/j.biopha.2022.113270. PMID:35709652. IF:7.500(Q1/1D).
01/08/2022
CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4+T lymphocytes
Jimenez-Fernandez, M, Rodriguez-Sinovas, C, Canes, L, Ballester-Servera, C, Vara, A, Requena, S, de la Fuente, H, Martinez-Gonzalez, J, Sanchez-Madrid, F. CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4+T lymphocytes. CELLULAR AND MOLECULAR LIFE SCIENCES. 2022; 79(8)DOI:10.1007/s00018-022-04481-1. PMID:35930205. IF:8.000(Q1/2D).
01/08/2022
Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G > C Variant in SMN2
Blasco-Perez, L, Costa-Roger, M, Leno-Colorado, J, Bernal, S, Alias, L, Codina-Sola, M, Martinez-Cruz, D, Castiglioni, C, Bertini, E, Travaglini, L, Millan, JM, Aller, E, Sotoca, J, Juntas, R, Hoei-Hansen, CE, Moreno-Escribano, A, Guillen-Navarro, E, Costa-Comellas, L, Munell, F, Boronat, S, Rojas-Garcia, R, Povedano, M, Cusco, I, Tizzano, EF. Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G > C Variant in SMN2. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15)DOI:10.3390/ijms23158289. PMID:35955418. IF:5.600(Q1/3D).
01/08/2022
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
Moreno, DF, Clapes, V, Soler, JA, Gonzalez-Montes, Y, Gironella, M, Motllo, C, Granell, M, Abella, E, Garcia-Pintos, M, Garcia-Guinon, A, Cabezudo, E, Blade, J, Rosinol, L. Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas. Clinical Lymphoma Myeloma & Leukemia. 2022; 22(8)DOI:10.1016/j.clml.2022.04.014. PMID:35610120. IF:2.700(Q3/7D).